Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
October-2018 Volume 40 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2018 Volume 40 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1

Corrigendum in: /10.3892/or.2024.8721
  • Authors:
    • Wei Zhao
    • Jin‑Xia Hu
    • Rui‑Min Hao
    • Qian Zhang
    • Jun‑Qi Guo
    • You‑Jie Li
    • Ning Xie
    • Lu‑Ying Liu
    • Ping‑Yu Wang
    • Can Zhang
    • Shu‑Yang Xie
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Tumor Molecular Biology in Binzhou Medical University, Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, Shandong 264003, P.R. China, Key Laboratory of Tumor Molecular Biology in Binzhou Medical University, Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, Shandong 264003, P.R. China, Department of Chest Surgery, YanTaiShan Hospital, YanTai, Shandong 264000, P.R. China, Department of Pathology, Binzhou Medical University, YanTai, Shandong 264003, P.R. China, Genetics and Aging Research Unit, Mass General Institute for Neurodegenerative Diseases (MIND), Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129‑2060, USA
    Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1843-1854
    |
    Published online on: July 24, 2018
       https://doi.org/10.3892/or.2018.6593
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lung cancer is the most common cause of cancer‑associated mortality. MicroRNAs (miRNAs), as oncogenes or tumor suppressor genes, serve crucial roles not only in tumorigenesis, but also in tumor invasion and metastasis. Although miRNA‑let‑7a (let‑7a) has been reported to suppress cell growth in multiple cancer types, the biological mechanisms of let‑7a in lung adenocarcinoma are yet to be fully elucidated. In the present study, the molecular roles of let‑7a in lung adenocarcinoma were investigated by detecting its expression in lung adenocarcinoma tissues and exploring its roles in the regulation of lung cancer cell proliferation. Let‑7a expression was identified to be downregulated in lung adenocarcinoma tissues compared with normal tissues. Overexpression of let‑7a effectively suppressed cancer cell proliferation, migration and invasion in H1299 and A549 cells. Let‑7a also induced cell apoptosis and cell cycle arrest. Furthermore, let‑7a significantly inhibited cell growth by directly regulating cyclin D1 signals. This novel regulatory mechanism of let‑7a in lung adenocarcinoma provides possible avenues for future targeted therapies of lung cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Geyik E, Igci YZ, Pala E, Suner A, Borazan E, Bozgeyik I, Bayraktar E, Bayraktar R, Ergun S, Cakmak EA, et al: Investigation of the association between ATP2B4 and ATP5B genes with colorectal cancer. Gene. 540:178–182. 2014. View Article : Google Scholar : PubMed/NCBI

2 

Ozcan O, Kara M, Yumrutas O, Bozgeyik E, Bozgeyik I and Celik OI: MTUS1 and its targeting miRNAs in colorectal carcinoma: Significant associations. Tumour Biol. 37:6637–6645. 2016. View Article : Google Scholar : PubMed/NCBI

3 

Ye L, Wang H and Liu B: miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1. Tumour Biol. 37:1151–1157. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Castro D, Moreira M, Gouveia AM, Pozza DH and De Mello RA: MicroRNAs in lung cancer. Oncotarget. 8:81679–81685. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Pan C, Wang D, Zhang Y and Yu W: MicroRNA-1284 inhibits cell viability and induces apoptosis of ovarian cancer cell line OVCAR3. Oncol Res. 24:429–435. 2016. View Article : Google Scholar : PubMed/NCBI

6 

Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA and Jacks T: Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA. 105:3903–3908. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Liu WL, Chang JM, Chong IW, Hung YL, Chen YH, Huang WT, Kuo HF, Hsieh CC and Liu PL: Curcumin inhibits LIN-28A through the activation of miRNA-98 in the lung cancer cell line A549. Molecules. 22:E9292017. View Article : Google Scholar : PubMed/NCBI

8 

Zhong Z, Dong Z, Yang L, Chen X and Gong Z: Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp The Med. 4:267–272. 2012. View Article : Google Scholar

9 

Pan L, Gong Z, Zhong Z, Dong Z, Liu Q, Le Y and Guo J: Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Mol Cell Biochem. 355:257–263. 2011. View Article : Google Scholar : PubMed/NCBI

10 

Braga TV, Evangelista FC, Gomes LC, Araujo S, Carvalho MD and Sabino AP: Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia. Biomed Pharmacother. 92:864–869. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Ru Y, Chen XJ, Zhao ZW, Zhang PF, Feng SH, Gao Q, Gao SG and Feng XS: CyclinD1 and p57kip2 as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma. Oncotarget. 8:73860–73870. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Zhou X, Sun F, Luo S, Zhao W, Yang T, Zhang G, Gao M, Lu R, Shu Y, Mu W, et al: let-7a is an antihypertrophic regulator in the heart via targeting calmodulin. Int J Biol Sci. 13:22–31. 2017. View Article : Google Scholar : PubMed/NCBI

13 

He M and Xue Y: MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3. Onco Targets Ther. 10:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Tang R, Yang C, Ma X, Wang Y, Luo D, Huang C, Xu Z, Liu P and Yang L: MiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in gastric cancer. Oncotarget. 7:5972–5984. 2016.PubMed/NCBI

15 

Shirali S, Aghaei M, Shabani M, Fathi M, Sohrabi M and Moeinifard M: Adenosine induces cell cycle arrest and apoptosis via cyclinD1/Cdk4 and Bcl-2/Bax pathways in human ovarian cancer cell line OVCAR-3. Tumour Biol. 34:1085–1095. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Li ZCJ, Yu Q, Wu X, Pan A and Li L: Evaluation of CCND1 amplification and CyclinD1 expression: Diffuse and strong staining of CyclinD1 could have same predictive roles as CCND1 amplification in ER positive breast cancers. Am J Transl Res. 8:142–153. 2016.PubMed/NCBI

17 

Wang YY, Ren T, Cai YY and He XY: MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm. 28:131–137. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Chen Z, Wang D, Gu C, Liu X, Pei W, Li J, Cao Y, Jiao Y, Tong J and Nie J: Down-regulation of let-7 microRNA increased K-ras expression in lung damage induced by radon. Environ Toxicol Pharmacol. 40:541–548. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Zhang YX, Yan YF, Liu YM, Li YJ, Zhang HH, Pang M, Hu JX, Zhao W, Xie N, Zhou L, et al: Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth. Cell Death Dis. 7:e25282016. View Article : Google Scholar : PubMed/NCBI

20 

Wang Y, Cheng N and Luo J: Downregulation of lncRNA ANRIL represses tumorigenicity and enhances cisplatin-induced cytotoxicity via regulating microRNA let-7a in nasopharyngeal carcinoma. J Biochem Mol Toxicol. 31:72017. View Article : Google Scholar

21 

Wang PY, Sun YX, Zhang S, Pang M, Zhang HH, Gao SY, Zhang C, Lv CJ and Xie SY: Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors. FEBS Lett. 587:2675–2681. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Cheng G, Wang X, Li Y and He L: let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem cell Res Ther. 8:342017. View Article : Google Scholar : PubMed/NCBI

23 

Fan YC, Zhu YS, Mei PJ, Sun SG, Zhang H, Chen HF, Chen C and Miao FA: Cullin1 regulates proliferation, migration and invasion of glioma cells. Med Oncol. 31:2272014. View Article : Google Scholar : PubMed/NCBI

24 

Wang G, Wang J, Zhao H, Wang J and Tony To S: The role of Myc and let-7a in glioblastoma, glucose metabolism and response to therapy. Arch Biochem Biophys. 580:84–92. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Detterbeck FC, Boffa DJ, Kim AW and Tanoue LT: The 8th edition lung cancer stage classification. Chest. 2016.doi:10.1016/j.chest.2016.10.010.

26 

Nakashima Y, Yao T, Hirahashi M, Aishima S, Kakeji Y, Maehara Y and Tsuneyoshi M: Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 59:841–849. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Kadota K, Suzuki K, Kachala SS, Zabor EC, Sima CS, Moreira AL, Yoshizawa A, Riely GJ, Rusch VW, Adusumilli PS, et al: A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol. 25:1117–1127. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Espinosa AM, Alfaro A, Roman-Basaure E, Guardado-Estrada M, Palma Í, Serralde C, Medina I, Juárez E, Bermúdez M, Márquez E, et al: Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer. PLoS One. 8:e559752013. View Article : Google Scholar : PubMed/NCBI

29 

Giordano TJ: The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma. Am J Surg Pathol. 35:471–473. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Li X, Hao Z, Fan R, Zou X, Jin H, Pan Y, He L, Du R, Gao L, Liu D, et al: CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27. Cancer Biol Ther. 6:1539–1545. 2007. View Article : Google Scholar : PubMed/NCBI

31 

Zhong Z, Yeow WS, Zou C, Wassell R, Wang C, Pestell RG, Quong JN and Quong AA: CyclinD1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res. 70:2105–2114. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Cho KJ, Song J, Oh Y and Lee JE: MicroRNA-let-7a regulates the function of microglia in inflammation. Mol Cell Neurosci. 68:167–176. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Jeong HC, Kim EK, Lee JH, Lee JM, Yoo HN and Kim JK: Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients. Mol Med Rep. 4:383–387. 2011.PubMed/NCBI

34 

Zhao BW, Zhou LF, Liu YL, Wan SM and Gao ZX: Evolution of Fish Let-7 MicroRNAs and their expression correlated to growth development in Blunt Snout Bream. Int J Mol Sci. 18:E6462017. View Article : Google Scholar : PubMed/NCBI

35 

Hunter T and Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 79:573–582. 1994. View Article : Google Scholar : PubMed/NCBI

36 

Seiler R, Thalmann GN, Rotzer D, Perren A and Fleischmann A: CCND1/CyclinD1 status in metastasizing bladder cancer: A prognosticator and predictor of chemotherapeutic response. Mod Pathol. 27:87–95. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Ghallab NA, Kasem RF, El-Ghani SF and Shaker OG: Gene expression of miRNA-138 and cyclin D1 in oral lichen planus. Clin Oral Investig. 21:2481–2491. 2017. View Article : Google Scholar : PubMed/NCBI

38 

Li J, Wei J, Mei Z, Yin Y, Li Y, Lu M and Jin S: Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. Am J Transl Res. 9:146–154. 2017.PubMed/NCBI

39 

Gómez-Crisóstomo NP, López-Marure R, Zapata E, Zazueta C and Martínez-Abundis E: Bax induces cytochrome c release by multiple mechanisms in mitochondria from MCF7 cells. J Bioenerg Biomembr. 45:441–448. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao W, Hu JX, Hao RM, Zhang Q, Guo JQ, Li YJ, Xie N, Liu LY, Wang PY, Zhang C, Zhang C, et al: Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721. Oncol Rep 40: 1843-1854, 2018.
APA
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y. ... Xie, S. (2018). Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721. Oncology Reports, 40, 1843-1854. https://doi.org/10.3892/or.2018.6593
MLA
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y., Xie, N., Liu, L., Wang, P., Zhang, C., Xie, S."Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721". Oncology Reports 40.4 (2018): 1843-1854.
Chicago
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y., Xie, N., Liu, L., Wang, P., Zhang, C., Xie, S."Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721". Oncology Reports 40, no. 4 (2018): 1843-1854. https://doi.org/10.3892/or.2018.6593
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao W, Hu JX, Hao RM, Zhang Q, Guo JQ, Li YJ, Xie N, Liu LY, Wang PY, Zhang C, Zhang C, et al: Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721. Oncol Rep 40: 1843-1854, 2018.
APA
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y. ... Xie, S. (2018). Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721. Oncology Reports, 40, 1843-1854. https://doi.org/10.3892/or.2018.6593
MLA
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y., Xie, N., Liu, L., Wang, P., Zhang, C., Xie, S."Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721". Oncology Reports 40.4 (2018): 1843-1854.
Chicago
Zhao, W., Hu, J., Hao, R., Zhang, Q., Guo, J., Li, Y., Xie, N., Liu, L., Wang, P., Zhang, C., Xie, S."Induction of microRNA‑let‑7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1 Corrigendum in /10.3892/or.2024.8721". Oncology Reports 40, no. 4 (2018): 1843-1854. https://doi.org/10.3892/or.2018.6593
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team